Disease progression pathways of wet AMD: opportunities for new target discovery.

Amber T WolfAlon HarrisFrancesco OddoneBrent SieskyAlice Verticchio VercellinThomas A Ciulla

Published in: Expert opinion on therapeutic targets (2022)

With novel targets and advancements in drug delivery, there is potential to address treatment burden and to improve outcomes for patients afflicted with neovascular AMD.

Keyphrases

drug delivery
age related macular degeneration
end stage renal disease
newly diagnosed
chronic kidney disease
small molecule
peritoneal dialysis
prognostic factors
type diabetes
risk factors
metabolic syndrome
patient reported outcomes
skeletal muscle
vascular endothelial growth factor
drug release